Study Evaluating Inotuzumab Ozogamicin In Acute Lymphocytic Leukemia

NCT01363297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Lymphocytic Leukemia

Interventions

DRUG: Inotuzumab Ozogamicin

Sponsor

Pfizer

Collaborators

[object Object]